This inventor holds 9 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Gunma University, Nec Solution Innovators, Ltd., Hitachi, Ltd.. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kiryu, JP (2014)
- Maebashi, JP (2019 - 2022)
- Gunma, JP (2020 - 2023)
Company Filing History:



Years Active: 2014-2023
Title: Masayasu Kuwahara: Innovator in Nucleic Acid Technologies
Introduction
Masayasu Kuwahara is a prominent inventor based in Maebashi, Japan. He has made significant contributions to the field of nucleic acid technologies, holding a total of nine patents. His work focuses on the development of novel nucleoside derivatives and methods for producing polynucleotides.
Latest Patents
Kuwahara's latest patents include a range of innovative technologies. These patents encompass a nucleoside derivative or salt thereof, a polynucleotide synthesis reagent, a method for producing polynucleotides, and a method for producing binding nucleic acid molecules. The nucleoside derivative is represented by a specific chemical formula, which includes various atomic groups and hydrocarbon chains. Additionally, he has developed a method for detecting target molecules using rolling circle amplification, which involves forming a complex of a target molecule, capture oligonucleotide, and single-stranded circular DNA.
Career Highlights
Throughout his career, Kuwahara has worked with esteemed institutions such as Gunma University and NEC Solution Innovators, Ltd. His research has significantly advanced the understanding and application of nucleic acid technologies.
Collaborations
Kuwahara has collaborated with notable colleagues, including Hirotaka Minagawa and Katsunori Horii. These partnerships have contributed to the success of his innovative projects.
Conclusion
Masayasu Kuwahara's contributions to nucleic acid technologies have established him as a key figure in the field. His patents and collaborative efforts continue to influence advancements in molecular biology and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile